Table 3.
ARIC | |||||||
TnT Category | 1 | 2 | 3 | 4 | 5 | P-trend | |
Range (ng/L) | < 3 | 3 to ≤ 5 | 5 to ≤ 8 | 8 to ≤ 13 | ≥ 13 | ||
N | 3252 | 2463 | 1928 | 1223 | 685 | ||
Total VTE | |||||||
N events | 58 | 42 | 44 | 39 | 24 | ||
Incidence rate per 1000 person-yrs | 2.15 | 2.08 | 2.87 | 4.11 | 4.86 | ||
Model 1 | 1.00 | 0.94 (0.63, 1.41) | 1.26 (0.84, 1.91) | 1.76 (1.13, 2.74) | 2.09 (1.24, 3.51) | 0.0007 | |
Model 2 | 1.00 | 0.92 (0.61, 1.38) | 1.15 (0.75, 1.74) | 1.40 (0.88, 2.22) | 1.65 (0.95, 2.87) | 0.04 | |
Model 3 | 1.00 | 1.02 (0.66, 1.57) | 1.23 (0.78, 1.95) | 1.39 (0.82, 2.35) | 1.66 (0.87, 3.16) | 0.08 | |
Unprovoked VTE | |||||||
N events | 21 | 11 | 22 | 17 | 3 | ||
Model 2 | 1.00 | 0.70 (0.33, 1.49) | 1.69 (0.88, 3.27) | 1.72 (0.81, 3.68) | 0.64 (0.17, 2.32) | 0.32 | |
Provoked VTE | |||||||
N events | 37 | 31 | 22 | 22 | 21 | ||
Model 2 | 1.00 | 1.02 (0.63, 1.66) | 0.86 (0.50, 1.50) | 1.23 (0.68, 2.21) | 2.16 (1.15, 4.06) | 0.06 | |
Model 2, not cancer related | 1.00 | 1.45 (0.72, 2.93) | 1.14 (0.51, 2.57) | 1.75 (0.75, 4.09) | 3.99 (1.70, 9.41) | 0.007 | |
Model 2, cancer related | 1.00 | 0.73 (0.37, 1.44) | 0.66 (0.31, 1.42) | 0.87 (0.38, 2.00) | 1.03 (0.37, 2.82) | 0.86 | |
CHS | |||||||
N | 1463 | 594 | 742 | 687 | 636 | P-trend | |
Total VTEa | |||||||
N events | 41 | 11 | 33 | 25 | 28 | ||
Incidence rate per 1000 person-yrs | 2.74 | 1.86 | 4.67 | 4.03 | 6.11 | ||
Model 1 | 1.00 | 0.65 (0.33, 1.26) | 1.58 (0.98, 2.53) | 1.25 (0.73, 2.13) | 1.87 (1.09, 3.21) | 0.01 | |
Model 2 | 1.00 | 0.60 (0.30, 1.20) | 1.47 (0.90, 2.38) | 1.14 (0.66, 1.96) | 1.70 (0.97, 2.99) | 0.05 | |
Model 3 | 1.00 | 0.56 (0.26, 1.20) | 1.27 (0.73, 2.21) | 0.98 (0.53, 1.82) | 1.48 (0.78, 2.83) | 0.74 | |
Unprovoked VTE | |||||||
N events | 15 | 4 | 12 | 11 | 7 | ||
Model 2 | 1.00 | 0.46 (0.13, 1.59) | 1.29 (0.58, 2.91) | 1.15 (0.48, 2.74) | 0.93 (0.33, 2.61) | 0.74 | |
Provoked VTE | |||||||
N events | 26 | 7 | 21 | 14 | 21 | ||
Model 2 | 1.00 | 0.69 (0.30, 1.59) | 1.58 (0.86, 2.88) | 1.11 (0.55, 2.24) | 2.29 (1.17, 4.51) | 0.03 | |
Model 2, not cancer related | 1.00 | 0.78 (0.28, 2.13) | 1.49 (0.69, 3.10) | 0.95 (0.37, 2.42) | 2.79 (1.22, 6.38) | 0.04 | |
Model 2, cancer related | 1.00 | 0.53 (0.12, 2.43) | 1.73 (0.66, 4.56) | 1.38 (0.47, 4.05) | 1.51 (0.45, 5.11) | 0.33 | |
POOLED - ARIC + CHS | |||||||
N | 4715 | 3057 | 2670 | 1910 | 1321 | P-trend | |
Total VTE | |||||||
N events | 99 | 53 | 77 | 64 | 52 | ||
Incidence rate per 1000 person-yrs | 2.36 | 2.03 | 3.44 | 4.08 | 5.46 | ||
Model 1 | 1.00 | 0.85 (0.61, 1.19) | 1.36 (1.00, 1.86) | 1.51 (1.07, 2.12) | 1.98 (1.36, 2.87) | <.0001 | |
Model 2 | 1.00 | 0.83 (0.59, 1.17) | 1.25 (0.91, 1.72) | 1.28 (0.90, 1.81) | 1.70 (1.15, 2.51) | 0.004 | |
Model 3 | 1.00 | 0.87 (0.61, 1.26) | 1.22 (0.86, 1.73) | 1.18 (0.80, 1.76) | 1.63 (1.04, 2.56) | 0.03 | |
Unprovoked VTE | |||||||
N events | 36 | 15 | 34 | 28 | 10 | ||
Model 2 | 1.00 | 0.61 (0.33, 1.15) | 1.48 (0.89, 2.46) | 1.41 (0.80, 2.48) | 0.84 (0.38, 1.82) | 0.37 | |
Provoked VTE | |||||||
N events | 63 | 38 | 43 | 36 | 42 | ||
Model 2 | 1.00 | 0.95 (0.63, 1.44) | 1.11 (0.74, 1.67) | 1.19 (0.76, 1.87) | 2.27 (1.43, 3.59) | 0.003 |
Model 1: Adjusted for age, sex, and race.
Model 2: Adjusted for Model 1 + diabetes status, BMI, eGFR and CRP.
Model 3: Adjusted for Model 2 + time-dependent censoring of CHD or heart failure during follow-up.
Three CHS events had missing data for TnT.